Influenza vaccination among cardiovascular disease sufferers in Spain: Related factors and trend, 1993-2003

Vaccine

Volumn 24, Issue 23, 2006, Pages 5073-5082

  Jiménez García, Rodrigo ^a   Hernández Barrera, Valentín ^a   Carrasco Garrido, Pilar ^a   del Pozo, Silvia Vázquez Fernández ^a   de Miguel, Ángel Gil ^a  

^a Health Sciences Faculty   (Spain)

Author keywords

Cardiovascular disease; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HEART DISEASE; HUMAN; HYPERTENSION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEX DIFFERENCE; SPAIN;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SPAIN; VACCINATION;

EID: 33646858292     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.03.036     Document Type: Article

References (46)

1. Harper S.A., Fukuda K., Uyeki T.M., Cox N.J., Bridges C.B., Advisory Committee on Immunization Practices (ACIP), and Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54 RR-8 (2005) 1-40
2. Madjid M., Awan I., Ali M., Frazier L., and Casscells W. Influenza and atherosclerosis: vaccination for cardiovascular disease prevention. Expert Opin Biol Ther 5 (2005) 91-96
3. Ajani U.A., Ford E.S., and Mokdad A.H. Examining the coverage of influenza vaccination among people with cardiovascular disease in the United States. Am Heart J 149 (2005) 254-259
4. Hak E., Buskens E., van Essen G.A., de Bakker D.H., Grobbee D.E., Tacken M.A., et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 165 (2005) 274-280
5. Voordouw A.C., Sturkenboom M.C., Dieleman J.P., Stijnen T., Smith D.J., van der Lei J., et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 292 (2004) 2089-2095
6. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., and Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 348 (2003) 1322-1332
7. Gurfinkel E.P., de la Fuente R.L., Mendiz O., and Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 105 (2002) 2143-2147
8. Costa Tadeo X., Navarro Aznarez G., Campos Abellana C., Esporrin Bosque C., and Romero Ruiz A.I. Evaluacion del no cumplimiento de un programa de vacunación antigripal. Aten Primaria 8 (1991) 544-546
9. van Essen G.A., Palache A.M., Forleo E., and Fedson D.S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 21 (2003) 1780-1785
10. LeBaron C.W., Chaney M., Baughman A.L., Dini E.F., Maes E., Dietz V., et al. Impact of measurement and feedback on vaccination coverage in public clinics. JAMA 277 (1997) 631-635
11. Kamal K.M., Madhavan S.S., and Amonkar M.M. Determinants of adult influenza and pneumonia immunization rates. J Am Pharm Assoc (Wash DC) 43 (2003) 403-411
12. Chapman B.C., and Coups E.J. Predictors of influenza vaccine acceptance among healthy adults. Prev Med 29 (1999) 249-262
13. Kroneman M., van Essen G.A., and John Paget W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 24 (2006) 622-628
14. Szucs T.D., and Müller D. Influenza vaccination coverage rates in five European countries - a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 23 (2005) 5055-5063
15. Kroneman M.W., van Essen G.A., Tacken M.A., Paget W.J., and Verheij R. Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine 22 (2004) 2163-2170
16. Jimenez-Garcia R., Mayo-Montero E., Hernandez-Barrera V., Sierra-Moros M.J., Pachon del Amo I., Carrasco-Garrido P., et al. Evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001. Vaccine 23 (2005) 2844-2850
17. Sarria A., and Timoner J. Determinantes de la vacunación de la gripe en personas mayores de 65 años. Rev Esp Salud Pública 76 (2002) 17-26
18. Subdirección General de Información Sanitaria y Estadisticas Sanitarias. Ministerio de Sanidad y Consumo. Encuesta Nacional de Salud de España 1993 (Spanish National Health Survey 1993). Madrid, Spain: Ministerio de Sanidad y Consumo; 1995.
19. INE. Instituto Nacional de Estadística. Encuesta Nacional de Salud de España 2003 (Spanish National Health Survey 2003). Available from http://www.ine.es/en/metodologia/t15/t1530419_en.pdf. Accessed January 17, 2006.
20. INE. Instituto Nacional de Estadística. Encuesta Nacional de Salud de España 2003 (Spanish National Health Survey 2003). Details on the evaluation of non respondents. Available from http://www.ine.es/daco/daco42/sanitarias/evaluacion.pdf. Accessed January 17, 2006.
21. Pleis J.R., and Gentleman J.F. Using the National Health Interview Survey: time trends in influenza vaccinations among targeted adults. Eff Clin Pract 5 Suppl 3 (2002) E3
22. Nelson D.E., Powell-Griner E., Town M., and Kovar M.G. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health 93 (2003) 1335-1341
23. Ford E.S., Mannino D.M., and Williams S.G. Asthma and influenza vaccination: findings from the 1999-2001 National Health Interview Surveys. Chest 124 (2003) 783-789
24. Centers for Disease Control and Prevention (CDC). Influenza vaccination levels among persons aged > or =65 years and among persons aged 18-64 years with high-risk conditions - United States. MMWR Morb Mortal Wkly Rep 54 (2005) 1045-1049
25. Medrano M.J., Cerrato E., Boix R., and Delgado-Rodriguez M. Factores de riesgo cardiovascular en la poblacion española: mataanalisis de estudios trasnversales. Med Clin (Barc) 124 (2005) 606-612
26. Sans S., Puigdefabregas A., Paluzie G., Monterde D., and Balaguer-Vintro I. Increasing trends of acute myocardial infarction in Spain: the MONICA-Catalonia Study. Eur Heart J 26 (2005) 505-515
27. Sanchez R.G., Novella Arribas B., Alonso Arroyo M., Vega Quiroga S., Lopez S G., Suarez Fernandez C., et al. El proyecto EPICARDIAN: un estudio de cohorts sobre enfermedades y factores de riesgo cardiovascular en ancianos españoles: consideraciones metodológicas y principales hallazgos demográficos. Rev Esp Salud Publica 78 (2004) 243-255
28. Singleton J.A., Wortley P., and Lu P.J. Influenza vaccination of persons with cardiovascular disease in the United States. Tex Heart Inst J 31 (2004) 22-27
29. Greenlund K.J., Zheng Z.J., Keenan N.L., Giles W.H., Casper M.L., Mensah G.A., et al. Trends in self-reported multiple cardiovascular disease risk factors among adults in the United States. Arch Intern Med 164 (2004) 181-188
30. Jimenez-Garcia R., Mayo-Montero E., Hernandez-Barrera V., Garrido P.C., Martinez-Hernandez D., and de Miguel A.G. Influenza vaccination among diabetic adults: related factors and trend from 1993 to 2001 in Spain. Diabetes Care 28 (2005) 2031-2033
31. Jimenez-Garcia R., Arinez-Fernandez M.C., Garcia-Carballo M., Hernandez-Barrera V., de Miguel A.G., and Carrasco-Garrido P. Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Vaccine 23 28 (2005) 3679-3686
32. Nicholson K.G., Kent J., and Hammersley V. Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-1994; cigarette smoking as a risk factor and the efficacy of influenza vaccination. Epidemiol Infect 123 (1999) 103-108
33. Lu P.J., Singleton J.A., Rangel M.C., Wortley P.M., and Bridges C.B. Influenza vaccination trends among adults 65 years or older in the United States 1989-2002. Arch Intern Med 165 (2005) 1849-1856
34. Honkanen P.O., Keistinen T., and Kivela S.L. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 15 (1997) 317-320
35. Centers for Disease Control and Prevention. Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 49 RR-3 (2000) 1-38
36. Gurfinkel E.P., and de la Fuente R.L. Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex Heart Inst J 31 (2004) 28-32
37. Grau A.J., Fischer B., Barth C., Ling P., Lichy C., and Buggle F. Influenza vaccination is associated with a reduced risk of stroke. Stroke 36 (2005) 1501-1506
38. Meyers D.G. Could influenza vaccination prevent myocardial infarction, stroke and sudden cardiac death?. Am J Cardiovasc Drugs 3 (2003) 241-244
39. Gurevich V.S., Pleskov V.M., and Levaya M.V. Autoimmune nature of influenza atherogenicity. Ann NY Acad Sci 1050 (2005) 410-416
40. CDC. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services. MMWR 54 RR-5 (2005)
41. Hak E., Hermens R.P., Hoes A.W., Verheij T.J., Kuyvenhoven M.M., and van Essen G.A. Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands. Scand J Prim Health Care 18 (2000) 237-241
42. Centers for Disease Control and Prevention. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults: a report on recommendations of the Task Force on Community Preventive Services. MMWR Morb Mortal Wkly Rep 48 (1999) 1-16
43. Mac Donald R., Baken L., Nelson A., and Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 16 (1999) 173-177
44. Hutchison B.G. Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost. Can J Public Health 80 (1989) 271-275
45. Zimmerman R.K., Raymund M., Janosky J.E., Nowalk M.P., and Fine M.J. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 21 (2003) 1486-1491
46. Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macro-epidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 23 (2005) 5133-5143